Azitra, Inc. (AZTR) vs Niki BioSolutions, Inc. (NIKI)

Azitra, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Azitra, Inc. and Niki BioSolutions, Inc. are of similar size ($4.7M and $4.4M). Niki BioSolutions, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.3×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against 42.6%. Azitra, Inc. has the higher net margin (0.00% vs −921.7%) and the lower return on invested capital (−1,272.5% vs 0.00%). Across the 13 metrics below, Azitra, Inc. leads on 8 and Niki BioSolutions, Inc. on 5.

Valuation

Metric AZTR NIKI Biotechnology median
P/E 1.27 n/m 10.60
P/S 2.50 n/m 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.47 n/m 0.66
EV/Sales (9.10) 1.25 9.02
Earnings yield 78.60% (418.75%) (32.88%)
Free cash flow yield (786.51%) 0.00% (23.13%)

Profitability

Metric AZTR NIKI Biotechnology median
Gross margin 100.00% (87.96%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (921.74%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) 0.00% (51.96%)
Return on assets (190.69%) 0.00% (46.06%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR NIKI Biotechnology median
Revenue growth (TTM) 58.18% 42.64% 6.76%
EPS growth (last fiscal year) 85.68% 75.64% 29.88%
Revenue growth, 5-year CAGR — 2.38% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR NIKI Biotechnology median
Debt to equity 0.00 0.25 0.00
Current ratio 4.86 0.78 4.97
Net debt to EBITDA 0.20 0.02 1.01

Dividend

Metric AZTR NIKI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZTR NIKI Biotechnology median
Market cap 4.39m 4.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack